The PPD clinical research business of Thermo Fisher Scientific Inc., the world leader in serving science, has been awarded the Eagle Award for the second consecutive year for its outstanding leadership, professionalism, integrity and dedication to advancing the clinical research profession through strong partnerships with research sites.
WILMINGTON, N.C.--(BUSINESS WIRE)-- The PPD clinical research business of Thermo Fisher Scientific Inc., the world leader in serving science, has been awarded the Eagle Award for the second consecutive year for its outstanding leadership, professionalism, integrity and dedication to advancing the clinical research profession through strong partnerships with research sites.
The Eagle Award is a highly regarded industry honor from the Society for Clinical Research Sites (SCRS) that recognizes the top clinical research organization (CRO) for exemplifying a site-focused approach to clinical trial management. SCRS site members nominated companies based on their experiences working with CROs serving the site and patient community, and the PPD clinical research business won the title based on votes from the global site community.
“This prestigious award reflects our focus on supporting and connecting with our site partners, which in turn helps enable us to best serve our customers in pursuit of their clinical research initiatives,” said David M. Johnston, Ph.D., senior vice president and president, clinical research, Thermo Fisher Scientific. “Our close relationships with research sites contribute to our ability to help deliver on the ambition we all share – helping deliver life-changing therapies to patients around the globe.”
The PPD clinical research business draws on decades of experience in collaborating with leading research sites and site networks worldwide to advance biopharmaceutical and biotech customers’ development programs. For investigators and physician practices new to clinical research, the business offers SiteCoach, a customized training program designed to help them navigate the complexities of patient recruitment, educate patients on their options and streamline trial administration. Additionally, the business offers Accelerated Enrollment Solutions (AES), providing customers access to its dedicated site network.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221017005530/en/
Source: Thermo Fisher
View this news release online at:
http://www.businesswire.com/news/home/20221017005530/en
